Microorganisms applied in probiotic products Yeasts LAB Saccharomyces cerevisiae Enterococcus faecalis Saccharomyces boulardii
Enterococcus faecium Lactococcus lactis subsp.
Kolodziej, "Systematic review with meta-analysis: Saccharomyces boulardii
supplementation and eradication of Helicobacter pylori infection," Alimentary Pharmacology & Therapeutics, vol.
Gunay, "Saccharomyces boulardii
expresses neuraminidase activity selective for a2,3-linked sialic acid that decreases Helicobacter pylori adhesion to host cells," APMIS, vol.
* Probiotics in yogurt, the fermented milk product kefir, and commercial probiotic products may help standard therapy work better and could lessen treatment side effects (look for Lactobacillus or Saccharomyces boulardii
demonstrated that children receiving Saccharomyces boulardii
, a component of several probiotic supplements, was initially classified as a novel species of the genus Saccharomyces.
(28) Various probiotics were used including Lactobacillus species, Streptococcus thermophilus, Bifidobacterium species, and Saccharomyces boulardii
for between 4 and 10 days.
Rampal, Saccharomyces boulardii
preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells, doi: 10.1128/IAI.68.10.5998-6004.2000, Infect Immun, 68(10), 5998-6004 (2000)
ENTEROL is an ethical pharmaceutical specialty composed of lyophilised Saccharomyces boulardii
living cells in a concentration of 250 mg per capsule, or per sachet registered in Romania in packs of 10 capsules and sachets under the trademark ENTEROL.
Se han reportado los Lactobacullus GG vivos, Lactobacillus acidophilus muertos LB, Saccharomyces boulardii
para ser ingeridos con Sales de Rehidratacion Oral, o en formulas glucosadas, en leche pasteurizada fermentada con cepas vivas de L.
Im and Pothoulakis (2010) report that the yeast Saccharomyces boulardii
is highly beneficial to the host because it alters bacterial virulence, releases toxin-breaking enzymes and decreases inflammatory response.
Major finding: The probiotic yeast Saccharomyces boulardii
does not appear to have any beneficial effects for patients with Crohn's disease who are in remission.